NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.26
-0.59 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
35.00
-0.26 (-0.74%)
After-hours: Dec 5, 2025, 6:50 PM EST
NAMS Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,998 | 2,751 | 920 | 889 | 139 | - |
| Market Cap Growth | 75.49% | 199.19% | 3.44% | 537.58% | - | - |
| Enterprise Value | 3,242 | 2,329 | 501 | 796 | 144 | - |
| Last Close Price | 35.26 | 25.70 | 11.17 | 10.90 | 9.75 | - |
| PS Ratio | 113.34 | 60.38 | 65.26 | 8.66 | - | - |
| PB Ratio | 5.48 | 3.63 | 3.19 | 2.07 | 2.46 | - |
| P/TBV Ratio | 5.49 | 3.64 | 3.19 | 2.07 | 2.46 | - |
| P/FCF Ratio | - | - | - | 85.12 | - | - |
| P/OCF Ratio | - | - | - | 83.36 | - | - |
| EV/Sales Ratio | 92.00 | 51.12 | 35.56 | 7.75 | - | - |
| EV/FCF Ratio | - | - | - | 76.18 | - | - |
| Debt / Equity Ratio | 0 | 0.00 | 0 | 0 | 0.00 | -3.26 |
| Debt / FCF Ratio | - | - | - | 0.01 | - | - |
| Asset Turnover | 0.06 | 0.08 | 0.03 | 0.38 | - | - |
| Quick Ratio | 12.41 | 8.00 | 6.86 | 13.03 | 5.81 | 0.61 |
| Current Ratio | 12.57 | 8.07 | 6.95 | 13.26 | 5.96 | 0.72 |
| Return on Equity (ROE) | -39.94% | -46.20% | -49.25% | -9.30% | -159.01% | - |
| Return on Assets (ROA) | -20.70% | -18.19% | -27.70% | -0.81% | -55.71% | - |
| Return on Capital (ROIC) | -22.90% | -21.06% | -31.82% | -0.91% | -66.25% | - |
| Return on Capital Employed (ROCE) | -27.90% | -23.30% | -61.60% | -0.80% | -61.60% | 151.80% |
| Earnings Yield | -5.53% | -8.78% | -19.24% | -2.55% | -29.97% | - |
| FCF Yield | -3.62% | -5.79% | -15.36% | 1.18% | -21.18% | - |
| Buyback Yield / Dilution | -25.71% | -14.84% | -333.20% | -72.75% | -119.58% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.